Trials / Conditions / Malignant Ovarian Serous Tumor

Malignant Ovarian Serous Tumor

3 registered clinical trials studyying Malignant Ovarian Serous Tumor.

Status	Trial	Sponsor	Phase
Terminated	Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persisten NCT02569957	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 2
Withdrawn	Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian NCT02470559	Barbara Ann Karmanos Cancer Institute	Phase 1
Terminated	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal NCT00899093	Gynecologic Oncology Group	—